UroGen Pharma Ltd.

URGN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$90,039$92,904$104,033$171,987
Short-Term Investments$36,994$64,050$91,857$64,698
Receivables$19,703$19,649$19,638$20,302
Inventory$8,341$7,128$7,590$9,227
Other Curr. Assets$1,347$1,082$14,059$9,921
Total Curr. Assets$168,546$196,868$237,177$276,135
Property Plant & Equip (Net)$9,184$6,239$5,380$3,789
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$380$4,632$4,514$5,022
Tax Assets$0$0$0$0
Other NC Assets$6,936$978$547$765
Total NC Assets$16,500$11,849$10,441$9,576
Other Assets$0$0$0$0
Total Assets$185,046$208,717$247,618$285,711
Liabilities
Payables$10,279$13,564$14,567$10,931
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,369$3,392$11,678$18,518
Total Curr. Liab.$42,244$47,548$42,000$45,949
LT Debt$122,111$122,508$122,108$121,734
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$129,858$128,624$127,127$125,178
Total NC Liab.$258,210$254,545$252,076$248,565
Other Liabilities$0$0$0$0
Cap. Leases$7,829$4,961$2,841$1,653
Total Liabilities$300,454$302,093$294,076$294,514
Equity
Pref Stock$0$0$0$0
Common Stock$128$126$126$115
Retained Earnings-$933,352-$900,005-$850,065-$806,222
AOCI$23$6$14$56
Other Equity-$0$0$0$0
Total Equity-$115,408-$93,376-$46,458-$8,803
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$185,046$208,717$247,618$285,711
Net Debt$32,072$29,604$18,075-$50,253
UroGen Pharma Ltd. (URGN) Financial Statements & Key Stats | AlphaPilot